Modern Healthcare: HHS Secretary Alex Azar said Tuesday that the Trump administration's proposal to tie prices for certain Medicare drugs to the prices wealthy countries pay overseas has already changed the dynamic around pharmaceutical prices "perhaps forever."
The secretary gave a full-throated defense of the administration's drug pricing blueprint released last May and singled out a controversial proposal to tie the price of physician-administered drugs under Medicare Part B to the average price that wealthy countries like Germany or Japan pay.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now